EWA
ETON icon

EverSource Wealth Advisors’s Eton Pharmaceutcials ETON Stock Holding History

EverSource Wealth Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326 Sell
9
-29
-76% -$850 ﹤0.01% 4188
2026
Q1 		$938 Buy
+38
New +$664 ﹤0.01% 3875

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

EverSource Wealth Advisors's ETON Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Eton Pharmaceutcials (ETON) stake by 76% in Q2 2026, selling an estimated $850 and leaving 9 shares worth $326. The position accounts for ﹤0.01% of the portfolio, ranked #4188.

EverSource Wealth Advisors first reported a position in ETON in Q1 2026 and has held it in 2 quarters since. The position peaked at $938 in Q1 2026. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • EverSource Wealth Advisors held 9 shares of Eton Pharmaceutcials worth $326 as of Q2 2026.
  • EverSource Wealth Advisors sold 29 Eton Pharmaceutcials shares in Q2 2026, an estimated $850.
  • Eton Pharmaceutcials made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4188 holding.
  • EverSource Wealth Advisors first reported a position in Eton Pharmaceutcials in Q1 2026 and has held it in 2 quarters since.
  • EverSource Wealth Advisors's Eton Pharmaceutcials position peaked at $938 in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.